Thailand Maintains Ban on E-Cigarette Imports.

Aug.31.2022
Thailand Maintains Ban on E-Cigarette Imports.
Thailand continues to prohibit the importation of electronic cigarettes to protect young people's health risks.

Thailand will not lift the ban on importing electronic cigarettes.


The government has officially confirmed its opposition to the use of electronic cigarettes, citing their negative impact on the health of users, more than half of whom are young people.


Anutin Charnvirakul, the Minister of Public Health, emphasized the need to continue the ban on importing electronic cigarettes during a national conference on smoking and public health held in Bangkok. This is to protect young people from the health risks associated with electronic smoking devices.


A survey conducted last year by Thailand's National Statistical Office found that more than half of the approximately 80,000 e-cigarette users in Thailand were between the ages of 15 and 24. "This clearly indicates that e-cigarettes are creating new smokers, especially among young people, and an increasing number of international studies have found that vaping has negative effects on the brains of young people," said Mr. Anutin.


He stated that Thailand has learned from the experiences of other countries in dealing with electronic cigarettes, and has found that currently there is no other option more effective than banning the import of electronic cigarettes for controlling their usage.


He said that cracking down on the smuggling of electronic cigarettes into the country would also continue to limit access to black market products.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the article content. The translation of this article is only for industry communication and research purposes.


Due to limitations in our translation skills, the translated article may not accurately convey the original message. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
The NSW Lower House passed a bill cracking down on illegal tobacco. It allows health authorities to shut down non-compliant shops for up to 90 days and sets penalties of up to 7 years in prison or A$1.5 million in fines for large-scale sales. The opposition-led bill, backed by the government, targets organized crime funding and enhances public safety.
Sep.12 by 2FIRSTS.ai
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australian police seize tons of illicit tobacco and millions of cigarettes in Victoria's largest illegal tobacco case.
Sep.11 by 2FIRSTS.ai
Heaven Gifts to Cease Sale of Flavored E-Cigarettes in California as Part of Settlement with NJOY: Court to Issue Permanent Injunction.
Heaven Gifts to Cease Sale of Flavored E-Cigarettes in California as Part of Settlement with NJOY: Court to Issue Permanent Injunction.
Heaven Gifts agrees to stop selling flavored disposable e-cigarettes in California as part of settlement with NJOY.
Oct.13 by 2FIRSTS.ai
Chile strengthens regulations on e-cigarette sales, bans sales to minors and restricts advertising in public places, health authorities intensify supervision to ensure compliance with new law
Chile strengthens regulations on e-cigarette sales, bans sales to minors and restricts advertising in public places, health authorities intensify supervision to ensure compliance with new law
Chile enforces new law tightening regulations on e-cigarette sales, bans sales to minors and prohibits public consumption.
Sep.16 by 2FIRSTS.ai
Philip Morris International's five-year EU investment exceeds €43 billion, generating nearly €290 billion in economic impact
Philip Morris International's five-year EU investment exceeds €43 billion, generating nearly €290 billion in economic impact
According to Ernst & Young Parthenon research, Philip Morris International (PMI) invested over 43 billion euros in the EU from 2019 to 2023. It brought nearly 290 billion euros in economic impact, supported about 1 million jobs (21,500 direct hires in 2023), put 19.6 billion euros into over 45,000 suppliers, spent 625 million euros on tobacco leaf procurement, 2.3 billion euros on R&D, and exported over 33 billion euros to non-EU markets.
Sep.19 by 2FIRSTS.ai